Acute Lymphoblastic Leukaemia
A randomized trial for adults with newly diagnosed acute lymphoblastic leukaemia.
For precursor-B lineage ALL, the main aim is to determine if the addition of Rituximab to standard induction chemotherapy results in improved EFS.
For T lineage ALL, the main aim is to determine if the addition of nelarabine following standard induction therapy improves outcomes.
United Kingdom National Randomised Trial For Children and Young Adults with Acute Lymphoblastic Leukaemia and Lymphoma 2011
A Phase 2 study for older adults with Acute Lymphoblastic Leukaemia